Saudi Central Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Saudi Central Bank's RPRX Position: Q2 2026 in Review
Saudi Central Bank increased its Royalty Pharma (RPRX) stake by 92% in Q2 2026, buying an estimated $718K and bringing the position to 28,773 shares worth $1.61M. The position accounts for 0.02% of the portfolio, ranked #378.
Saudi Central Bank first reported a position in RPRX in Q1 2025 and has held it in 3 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Saudi Central Bank held 28,773 shares of Royalty Pharma worth $1.61M as of Q2 2026.
- Saudi Central Bank bought 13,791 Royalty Pharma shares in Q2 2026, an estimated $718K.
- Royalty Pharma made up 0.02% of Saudi Central Bank's portfolio in Q2 2026, its #378 holding.
- Saudi Central Bank first reported a position in Royalty Pharma in Q1 2025 and has held it in 3 quarters since.
- 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.